Status:
RECRUITING
Effect of Magnesium on Neuromonitoring
Lead Sponsor:
University of California, San Francisco
Conditions:
Spine
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Intraoperative neurophysiologic monitoring (IONM) is commonly used during complex spinal surgery to monitor the integrity of neural structures and improve the perioperative safety profile. Transcrania...
Detailed Description
Spinal surgeries continue to increase in frequency and complexity, with the potential to cause injury to neural structures. Intraoperative neurophysiologic monitoring (IONM) is a crucial tool in spina...
Eligibility Criteria
Inclusion
- Adult patients (\>18 years of age) undergoing open thoracolumbar fusion with planned neuromonitoring
Exclusion
- Patients with a history of significant cardiac disease (LVEF \<35%, 2nd/3rd-degree block without a pacemaker, or significant arrhythmia)
- Patients with kidney disease (GFR \<30), or hepatic dysfunction (history of cirrhosis)
- Allergy or sensitivity to magnesium
- Patient with neuromuscular disease such as myasthenia graves
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06975072
Start Date
July 1 2025
End Date
April 30 2026
Last Update
July 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco Hospital
San Francisco, California, United States, 94143